FUMAGALLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 6.779
AS - Asia 3.501
EU - Europa 3.006
SA - Sud America 498
AF - Africa 69
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.885
Nazione #
US - Stati Uniti d'America 6.635
SG - Singapore 1.279
CN - Cina 912
IT - Italia 554
RU - Federazione Russa 548
HK - Hong Kong 511
DE - Germania 489
SE - Svezia 451
BR - Brasile 408
VN - Vietnam 397
IE - Irlanda 269
GB - Regno Unito 216
CA - Canada 97
IN - India 91
FR - Francia 87
UA - Ucraina 79
DK - Danimarca 66
ID - Indonesia 63
TR - Turchia 56
FI - Finlandia 42
AR - Argentina 40
AT - Austria 38
JP - Giappone 36
LT - Lituania 33
KR - Corea 32
ZA - Sudafrica 31
MX - Messico 29
NL - Olanda 29
BD - Bangladesh 24
PL - Polonia 23
AU - Australia 22
BE - Belgio 21
ES - Italia 20
EG - Egitto 17
EC - Ecuador 16
SA - Arabia Saudita 14
IQ - Iraq 13
IR - Iran 10
PY - Paraguay 10
KZ - Kazakistan 9
TW - Taiwan 9
CH - Svizzera 8
UY - Uruguay 8
CO - Colombia 7
HR - Croazia 6
PK - Pakistan 6
RO - Romania 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
BG - Bulgaria 5
CZ - Repubblica Ceca 5
EU - Europa 5
VE - Venezuela 5
CR - Costa Rica 4
DZ - Algeria 4
ET - Etiopia 4
JO - Giordania 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
GT - Guatemala 3
IL - Israele 3
NP - Nepal 3
PE - Perù 3
PH - Filippine 3
RS - Serbia 3
TN - Tunisia 3
AO - Angola 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
LB - Libano 2
MY - Malesia 2
OM - Oman 2
SC - Seychelles 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
CL - Cile 1
CY - Cipro 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TC - Turks e Caicos 1
TG - Togo 1
TL - Timor Orientale 1
Totale 13.885
Città #
Ann Arbor 1.897
Singapore 788
Dallas 597
Hong Kong 510
Ashburn 487
Wilmington 347
Chandler 323
Frankfurt am Main 274
Dublin 261
Dearborn 236
Milan 232
Woodbridge 185
New York 179
Houston 155
Santa Clara 143
Fairfield 139
Princeton 134
Beijing 132
Los Angeles 120
Nanjing 113
Ho Chi Minh City 95
Jacksonville 88
Boardman 77
Hanoi 69
Seattle 68
Moscow 65
Guangzhou 63
Shanghai 49
Jakarta 48
The Dalles 46
Nanchang 42
Buffalo 41
Dong Ket 41
Chicago 39
São Paulo 38
Cambridge 37
Lawrence 32
Vienna 31
Munich 30
Shenyang 29
Vilnius 27
Altamura 26
Hangzhou 25
Hefei 24
Zhengzhou 24
Toronto 23
Denver 21
Montreal 21
Phoenix 21
Pune 21
Shangdi 21
Council Bluffs 20
Jinan 20
Orem 19
Ottawa 19
Atlanta 17
Brussels 17
Kunming 17
London 17
Sacramento 17
Brooklyn 16
Rio de Janeiro 16
Sydney 16
Tianjin 16
Warsaw 16
Andover 15
Changsha 15
Fremont 15
Tokyo 15
Falls Church 14
Kent 14
Kocaeli 14
Mainz 14
Poplar 14
Portland 14
Belo Horizonte 13
Johannesburg 13
Redondo Beach 13
Stockholm 13
Chennai 12
Edmonton 12
Ha Long 12
Haiphong 12
Mexico City 12
Nuremberg 12
Rome 12
San Diego 12
Helsinki 11
Jiaxing 11
Lissone 11
Guarulhos 10
Manchester 10
Norwalk 10
San Francisco 10
Turku 10
Cairo 9
Hebei 9
Lachine 9
Paris 9
San Jose 9
Totale 9.197
Nome #
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 391
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 380
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 378
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 370
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 332
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 321
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 319
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 314
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 308
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 308
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 303
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 291
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 269
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 265
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 258
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 254
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 247
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 246
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 245
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 238
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 230
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 230
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 230
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 228
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 228
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 226
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 219
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 218
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 217
Genetic factors influencing the development of vincristine-induced neurotoxicity 214
Multimodal experimental approach to the study of human neurological diseases 206
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 201
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 194
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 191
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 189
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 188
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 183
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 178
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 177
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 176
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 174
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 173
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 172
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 171
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 170
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 170
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 170
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 169
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 168
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 168
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 167
In vitro neurotoxicity of new promising metal-based anticancer complexes 164
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 162
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 162
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 162
Pharmacokinetics of IVIg in Wistar rats 159
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 158
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 154
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 144
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 142
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 140
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 135
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 135
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 132
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 131
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 129
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 129
Blood NfL as a potential axonal damage marker in different CIPN rat models. 110
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 100
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 94
Totale 14.674
Categoria #
all - tutte 47.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.462 0 0 0 0 0 216 253 252 189 148 163 241
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20252.773 139 363 248 115 236 92 189 97 286 396 222 390
2025/20263.595 754 464 855 581 633 308 0 0 0 0 0 0
Totale 14.674